Abstract:Fibrotic remodelling is a highly conserved protective response to tissue injury and it is essential for the maintenance of structural and functional tissue integrity. Also hepatic fibrosis can be considered as a wound-healing response to liver injury, reflecting a balance between liver repair and scar formation. In contrast, pathological fibrosis corresponds to impaired wound healing. Usually, the liver regenerates after acute injury. However, if the damaging mechanisms persist, the liver reacts with progressive and uncontrolled accumulation of extracellular matrix proteins. Eventually, excessive fibrosis can lead to cirrhosis and hepatic failure. Furthermore, cirrhosis is the major risk factor for the development of hepatocellular cancer (HCC). Therefore, hepatic fibrosis is the most critical pathological factor that determines the morbidity and mortality of patients with chronic liver disease. Still, no effective anti-fibrogenic therapies exist, despite the very high medical need. The regulation of fibroblast growth factor (FGF) signalling is a prerequisite for adequate wound healing, repair and homeostasis in various tissues and organs. The FGF family comprises 22 proteins that can be classified into paracrine, intracrine and endocrine factors. Most FGFs signal through transmembrane tyrosine kinase FGF receptors (FGFRs). Although FGFRs are promising targets for the treatment of HCC, the expression and function of FGFR-ligands in hepatic fibrosis is still poorly understood. This review summarizes the latest advances in our understanding of FGF signalling in hepatic fibrosis. Furthermore, the potential of FGFs as targets for the treatment of hepatic fibrosis and remaining challenges for the field are discussed.

Progress of connective tissue growth factor in child hepatic fibrosis

The mechanism of profibrotic effect of connective tissue growth factor

Basic and clinical research of liver cirrhosis]

Connective Tissue Growth Factor Expression in Experimental Hepatic Fibrosis.

Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases

Mechanism of transforming growth factor beta/Smad signaling and the relationship between its transduction and liver fibrosis]

Research progress on roles of immune factors in development of hepatic fibrosis

Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities

Advances of bone marrow mesenchymal stem cells in hepatic fibrosis

Transforming Growth Factor-β Pathway and Molecular Treatment of Liver Fibrosis

Collagen-binding fibroblast growth factor ameliorates liver fibrosis in murine bile duct ligation injury

Liver Fibrosis: the Status Quo and the Prospect

Research Progress in Mechanism and Treatment of Hepatic Fibrosis

Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis

Fibrinogen improves liver function via promoting cell aggregation and fibronectin assembly in hepatic spheroids

Effects and potential mechanisms of IGF1/IGF1R in the liver fibrosis: A review

Role of fibroblast growth factor signalling in hepatic fibrosis

Research of the Anti-Fibrosis Factors Affecting Liver Regeneration after Partial Hepatectomy for Hepatic Cellular Carcinoma with Liver Cirrhosis

[Effects of Growth Factors and Extracellular Matrix on Proliferation and Differentiation of Fetal Liver Progenitor Cell in Vitro].

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

Hepatic differentiation of bone marrow mesenchymal stem cells induced by additional growth factors inhibits chronic liver fibrosis